Introduction
Small intestine "webs" are increasingly appreciated to play a role in a spectrum of small bowel pathology, including occult gastrointestinal bleeding, enteropathy and intermittent partial small bowel obstruction. The prevalence of small bowel webs is not known, but autopsy series suggest that specific adult populations may demonstrate stricture related lesions in 1.5 -9% of individuals (1) (2) (3) .
Late radiation injury of the small intestine may take years, with a median of about 8-12 months before the injury becomes apparent (4;5) . The clinical signs and symptoms of chronic radiation intestinal injury may be multifactorial in etiology. The chief problems that may require major medical or surgical intervention are intestinal obstruction, severe bleeding, fistula formation, and intractable diarrhea (4) (5) (6) . The radiologic picture of late radiation injury is of fibrosis and ischemia. These lesions are frequently missed in standard endoscopy and contrast studies of the upper and lower gastrointestinal tract. Capsule endoscopy is a new method that permits the endoscopic examination of the mucosa of the entire small bowel. The advent of wireless capsule endoscopy has increased diagnostic yield in patients with negative contrast studies. Using this technique, mucosal "webs" may be found in review of the video study or by capsule retention. In this paper, we describe a case of radiation ileal "web", diagnosed by capsule endoscopy, and its association with local, acquired microvascular dysfunction and impaired vasodilator capacity.
Case report
A 40-year-old female, with a medical history significant for external beam radiation treatment of a T2N0M0 squamous cell anal cancer was evaluated for symptoms of small bowel obstruction. She had received anal canal/inguinal node irradiation of 3060 cGy in 17 daily fractions (18MV x-rays) with reduced field anal irradiation 1980 cGy (18MV x-rays) and 1980 cGy bilateral inguinal node irradiation (9MeV electrons) in 11 fractions, completed 18 months prior. This brought the tumor dose to 5040 cGy. The patient received concurrent chemotherapy. Within 12 months of the radiation treatment, she experienced small bowel obstruction due to stricture formation and rectal sphincter damage requiring terminal ileal resection, primary anastomosis, and diverting sigmoid colostomy. During this procedure the remaining small intestine was carefully assessed for the presence of occult strictures using intraoperative passage and withdrawal of a balloon catheter inflated to a diameter of 2 to 2.5 cm through an enterotomy (7) . Six months later, she again experienced symptoms of partial small bowel obstruction, which led to the current admission. Radiographic studies (plain radiographs, CT, small bowel barium radiographs) and endoscopic studies (upper endoscopy, stoma colonoscopy) were nondiagnostic. Wireless capsule enteroscopy ( Figure 1A ) resulted in capsule retention ( Figure 1B ) at an ileal web stricture ( Figure 1C ); felt to be the cause of her symptoms. The patient underwent exploratory laparotomy, during which two webs in a 25 cm ileal segment were identified and resected. The resected tissues, including the "webs" and the adjacent normal caliber intestine, were used for physiologic studies and pathologic analysis.
Material and Methods
The Medical College of Wisconsin's Institutional Review Board approved all protocols. Mucosal gut arterioles were dissected from the full thickness specimen from both strictured and normal caliber small bowel. Following resection, tissue samples were preserved as reported previously (8) .
Microvessels physiology studies:
Videomicroscopy was performed as previously reported (8) . Briefly, isolated microvessels from the strictured and normal caliber small intestine were carefully dissected from the submucosal surface of the bowel tissue and transferred to a 20 ml organ chamber containing Krebs solution of the following composition (in mmol/L): NaCl 118, KCl 4.7, CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 20, Na 2 EDTA 0.026, and glucose 11, pH 7.4. Each end of the arteriole was secured to a separate glass micropipette (25-50 µm internal diameter) filled with Krebs buffer (9) and transferred to the stage of an inverted microscope (CK2, Olympus) coupled to a CCD camera (WV-BL200, Panasonic) and video micrometer (VIA-100K, Boeckeler Instruments, Inc.).
Internal vascular diameters were measured throughout the experiment with a manually adjusted video-microscope as described previously (9) . Micropipettes were connected to a hydrostatic reservoir at a final pressure of 60 mmHg. The chamber solution was continuously re-circulated at 30 ml/min, aerated with 20% O 2 , 5% CO 2 , and 75% N 2 , and warmed to 37 o C by an external heat changer. All pharmacological agents were added to the external bathing solution.
After a 60-min stabilization period, vessels were constricted to 30 -50% of maximal diameter (at 60 mmHg) with administration of endothelin-1 (10 -10 to 5x10 -10 M). Vascular diameter responses to cumulative logarithmic increases in the concentration of Ach (10 -9 to 10 -4 M) in the external bathing media were examined. At the end of each experiment, passive vessel diameter was determined by adding papaverine (10 -4 M). The addition of pharmacological agents produced less than 1% change in the volume of the circulating bath. All chemicals were obtained from Sigma Chemical Co. (St. Louis, MO).
Fluorescence Detection of ROS:
The cell-permeable dye dihydroethidine (HE, Molecular Probes, Eugene, OR) was used to evaluate the production of superoxide (O 2 ·-). In the presence of superoxide, HE is oxidized to ethidium bromide, which remains trapped within the cell (10). Ethidium bromide fluorescence was excited by light at a 488-nm wavelength with an emission spectrum of 620 nm, and examined under confocal microscopy equipped with a krypton/argon laser fluorescence microscope (Nikon Eclipse, TE 200). A freshly isolated artery from normalcaliber gut was used as a control to adjust for laser settings. Those settings were maintained constant throughout the remained of the experiment. The fluorescence intensity/vascular area ratio of the central portion of the vessel was normalized to that obtained from the control vessel using the public domain NIH Image program (developed at the U.S. National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image/). The ratio of the fluorescence intensity between experimental vessel and control vessel was compared.
To evaluate the in situ production of all ROS (superoxide, hydrogen peroxide, and peroxynitrite), vessels were loaded with 5 X 10 -6 M DCF-DA. DCF-DA oxidizes rapidly to the highly fluorescent 2',7'-dichlorofluorescein in the presence of ROS (8;10) and was visualized on a fluorescence microscope. Captured digital images were analyzed as described above.
Tissue histology and immunostaining:
Paraffin embedded sections of the strictured and normal caliber intestine were examined under light microscopy with H & E staining. Presence of an intact endothelial monolayer was assessed using CD 34 antibody immunodetection (DakoCytomation, Carpinteria, CA, USA) with horseradish peroxide resolution.
Materials:
Endothelin-1 (Peninsula Laboratories, Inc, San Carlos, CA) was prepared in saline with 1% bovine serum albumin. Other agents were prepared in distilled water. Final molar concentrations of agents in the organ chambers are reported. None of the pharmacological antagonists produced significant changes in baseline microvessels diameter.
Results
Microvessels from the stricture and macroscopic intervening normal areas of small bowel were isolated and studied using physiologic assessment for endothelium dependent vasorelaxation in response to Ach (10 -9 -10 -4 M) following partial constriction with endothelin-1 using previously published protocols (8) . Ach-induced vasodilation was reduced in vessels from two areas of intestinal web strictures (Max diameter (MD) = 7 ± 2%, n = 3) compared to the adjacent normal-caliber bowel microvessels (MD = 85 ± 5%, p = <0.01) ( Figure 1D ). Maximal dilation to papaverine was similar in vessels from the area of the web (86 ± 4.6%) compared to remote regions (89 ± 5.2%). Dihydroethidine and dichlorofluorescein diacetate (DCF-DA) staining were used to assess intravital production of ROS (8;10). Increased ROS were seen in microvessels isolated from previously irradiated area containing the stricture compared to vessels from the adjacent, preserved bowel ( Figure 1E ). Histology of the intestinal strictures demonstrated narrowing of the arteriolar lumen due to intimal thickening and muscularis propria fibrosis, which was not seen in the adjacent, preserved bowel (Figure 1 F) . Immunostaining for CD34 demonstrated preserved endothelial anatomy in the strictured microvessels ( Figure 1G ) (11;12).
Discussion
We report the association of a local, acquired microvascular dysfunction with impaired vasodilator capacity and elevated ROS production from microvessels localized to the area of stricture formation and not from vessels isolated from adjacent histologically normal bowel segments. This association of microvascular dysfunction in areas of stricture formation in a patient with recurrent small bowel obstruction following radiation therapy is a novel insight into the pathophysiology of radiation enteritis. This patient presented with a two-year history of gastrointestinal dysfunction following successful radiation therapy for anal squamous cell carcinoma. The patient presented with two episodes of small bowel obstruction requiring resection within eighteen months of treatment. We speculate that the vascular dysfunction was localized to the endothelium since only impaired dilation to Ach (an endothelial-dependent vasodilator) and not to papaverine (an endothelialindependent vasodilator) was affected.
Radiation therapy is an effective modality for pelvic tumors, but may be associated with gastrointestinal complications. Radiation-induced complications in tissues have been carefully calculated defining dose-effect relationships (Nominal Standard Dose/Tolerance Dose). The minimal and maximal tolerance doses (TD 5/5 and TD 50/5 ) are 4500-6500 cGy, respectively, for human small bowel injury, describing 5 -50% rates of injury within 5 years following exposure (13) . Chronic radiation injury to the intestine contributes to fibrosis and vascular insufficiency (chronic ischemia) (4;14;15). The rates of radiation induced bowel adverse reactions range between 5-25% (4). Grossly, the intestine with chronic radiation injury has been described as fibrotic with adhesions and a mottled appearance (4). The mucosa can appear pale and telangiectatic. Consistent with this report, the area of radiation injury is multifocal with relatively normal-appearing segments of bowel located immediately adjacent to the web. Taken together this line of evidence suggests radiation induced bowel injury is a localized vascular phenomenon (4;15) . The most common portions of the intestine involved reflect the clinical application of radiation therapy and include cecum, terminal ileum, rectum, and distal sigmoid (16;17) .
Vascular endothelium plays an essential role in the regulation of vascular tone and tissue perfusion through the release of nitric oxide (NO), prostacyclin, endothelial derived hyperpolarizing factor (EDHF), in response to physiological stimuli including Ach (8) . Microvascular dysfunction has been identified in human disease states, including diabetes mellitus, hyperlipidemia and inflammatory bowel disease, and is characterized by impaired endothelium-dependent vasodilation (8) . Interestingly, the chronic microscopic radiation induced changes are localized to submucosa. In contrast, the pathological effects of acute radiation induced injury are observed in the mucosal layer (15) . The normal submucosa is characterized by atypical fibroblast and collagen proliferation. Small arteries show hyalinized thickening of the wall with intimal foam cell proliferation and recanalized fibrin thrombi within the lumen.
The present study demonstrates that radiation induced bowel injury is also associated with an acquired local microvascular dysfunction which manifests as impaired vasodilator capacity. We hypothesize that this local microvascular dysfunction initiated by chronic elevations in ROS production following external beam ionizing radiation predisposes the bowel to ischemia and ultimately web formation. In addition, these data suggest that ROS formation is a therapeutic target in long-term radiation effects on bowel, potentially preventing the impaired perfusion and subsequent web formation. Further studies investigating the short and long-term effect of therapeutic radiation (and chemotherapy) on the human gut microvasculature and associated bowel complications are warranted.
Figure Legend:
Microvascular dysfunction is associated with radiation enteritis induced intestinal strictures. Wireless capsule endoscopic appearance of radiated nonstenotic ileum (A); Abdominal radiograph demonstrating capsule retention (B); Capsule endoscopic appearance of an ileal "web" following radiation therapy (C); Ach-induced dilation of microvessels from radiation induced intestinal stricture and adjacent normal caliber intestine (D); ROS production from intestinal arterioles isolated from "web" and normal caliber bowel (E); Histology of radiation induced stricture (F); Endothelial staining with CD34 immunolocalization in the radiation induced intestinal web demonstrating preservation of endothelial layer in stricture microvessels (G). Consent from the patient regarding the publication of this case report and the images were obtained.
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